Could pramipexole induce acute mania? A case report

Bipolar Disorders

Volumn 15, Issue 4, 2013, Pages 446-448

  Bet, Pierre M ^a   Franken, Linda Gw ^a   Klumpers, Ursula Mh ^b  

^a Dept Infectious Diseases AIDS and Tropical Medicine   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute mania; Bipolar disorder; Olanzapine; Pramipexole; Side effects

Indexed keywords

CREATININE; LITHIUM; MIRTAZAPINE; OLANZAPINE; OXAZEPAM; PRAMIPEXOLE; BENZODIAZEPINE DERIVATIVE; BENZOTHIAZOLE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; AGITATION; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; CASE REPORT; GLOMERULUS FILTRATION RATE; HUMAN; INSOMNIA; KIDNEY DONOR; KIDNEY TRANSPLANTATION; MALE; MANIA; MONOTHERAPY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SELF MEDICATION; TREMOR; AKATHISIA, DRUG-INDUCED; BIPOLAR DISORDER; COMPLICATION; DRUG COMBINATION; DRUG INTERACTION; HOSPITALIZATION; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

AKATHISIA, DRUG-INDUCED; BENZODIAZEPINES; BENZOTHIAZOLES; BIPOLAR DISORDER; DOPAMINE AGONISTS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 84878897372     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12067     Document Type: Article

References (19)

1. Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60: 1079-1088.
2. Tohen M, Calabrese JR, Sachs GS et al. Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 2006; 163: 247-256.
3. Connolly KR, Thase ME. The clinical management of bipolar disorder: a review of evidence-based guidelines. Prim Care Companion CNS Disord 2011; 13. doi: 10.4088/PCC.10r01097.
4. Fountoulakis KN, Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 2008; 11: 999-1029.
5. Willner P. The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol 1997; 12 (Suppl. 3): S7-S14.
6. Ishibashi K, Ishii K, Oda K, Mizusawa H, Ishiwata K. Binding of pramipexole to extrastriatal dopamine D2/D3 receptors in the human brain: a positron emission tomography study using 11C-FLB 457. PLoS ONE 2011; 6: e17723.
7. El-Mallakh RS, Penagaluri P, Kantamneni A, Gao Y, Roberts RJ. Long-term use of pramipexole in bipolar depression: a naturalistic retrospective chart review. Psychiatr Q 2010; 81: 207-213.
8. Goldberg JF, Burdick KE, Endick CJ. Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression. Am J Psychiatry 2004; 161: 564-566.
9. Zarate CA Jr, Payne JL, Singh J et al. Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biol Psychiatry 2004; 56: 54-60.
10. Sporn J, Ghaemi SN, Sambur MR et al. Pramipexole augmentation in the treatment of unipolar and bipolar depression: a retrospective chart review. Ann Clin Psychiatry 2000; 12: 137-140.
11. Factor SA, Molho ES, Podskalny GD, Brown D. Parkinson's disease: drug-induced psychiatric states. Adv Neurol 1995; 65: 115-138.
12. Singh A, Althoff R, Martineau RJ, Jacobson J. Pramipexole, ropinirole, and mania in Parkinson's disease. Am J Psychiatry 2005; 162: 814-815.
13. Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007; 41: 674-680.
14. De Boer T, Nefkens F, Van Helvoirt A. The alpha 2-adrenoceptor antagonist Org 3770 enhances serotonin transmission in vivo. Eur J Pharmacol 1994; 253: R5-R6.
15. Sharma V, Smith A. A case of mania following the use of pramipexole. Am J Psychiatry 2007; 164: 351.
16. Kelleher JP, Centorrino F, Huxley NA et al. Pilot randomized, controlled trial of pramipexole to augment antipsychotic treatment. Eur Neuropsychopharmacol 2012; 22: 415-418.
17. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: therapeutic implications. Am J Psychiatry 2008; 165: 830-843.
18. Ekbom K, Ulfberg J. Restless legs syndrome. J Intern Med 2009; 266: 419-431.
19. Rottach KG, Schaner BM, Kirch MH et al. Restless legs syndrome as side effect of second generation antidepressants. J Psychiatr Res 2008; 43: 70-75.